Fulgent Genetics, Inc.

US$23.74As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:FLGTHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 10.16%
Div yield —
ROE (8.74%)
Diagnostics & Research
Beta (5Y) 1.02
PE TTM —
TSR TTM 5.75%
Mkt cap US$663.3M
ROIC (16.88%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$31
29.48%
(23.32%)
Hold 5|5|4|6|1
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.27
0.30
0.32
0.32
4.08%
15.32%
17.54%
13.74%
Revenue$M
68.57
71.76
73.42
75.97
(1.90%)
5.76%
3.25%
7.48%
Peers (US$663.3M)
Cap (US$)
PE
1.094B
—
Capital
TTM
5Y
10Y
Leveragex
1.420
0.143
0.119
EBIT/Intx
0.453
0.284
0.266
Own earn%
(20.12)
(99.84)
(74.48)
Sh yield%
11.12
24.65
21.50
Owners
Insiders/Inst%
14.22
68.69
Short interest%
2.06
SBC / revenue%
5.14
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
14–18
$1 testx
0.1
Incr. ROIC%
2